None of the participants had serious adverse reactions during the study.
None of the participants stopped taking study treatment due to adverse reactions.
What serious adverse reactions happened during this study?
None of the participants had serious adverse reactions during the study.
What adverse reactions happened during this study?
The most common adverse reaction was an injection site reaction.
The table below shows the adverse reactions that happened during the study.
Some participants had more than 1 adverse reaction.
Adverse reactions
Part A Part B
MEDI6570 Placebo MEDI6570 Placebo
(out of 36 (out of 12 (out of 30 (out of 10
participants) participants) participants) participants)
Injection site reaction 2.8% (1) 0.0% (0) 3.3% (1) 10.0% (1)
Nausea 2.8% (1) 8.3% (1) 0.0% (0) 0.0% (0)
Diarrhea 0.0% (0) 8.3% (1) 0.0% (0) 10.0% (1)
Loss of the outer layer of skin at 0.0% (0) 8.3% (1) 0.0% (0) 0.0% (0)
the injection site
Headache 0.0% (0) 8.3% (1) 0.0% (0) 0.0% (0)
Low appetite 0.0% (0) 0.0% (0) 3.3% (1) 0.0% (0)
10 | Clinical Study Results